Black Rock Inc. Neogenomics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Black Rock Inc. holds 19,670,074 shares of NEO stock, worth $203 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,670,074
Previous 19,850,864
0.91%
Holding current value
$203 Million
Previous $312 Million
12.57%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
292Shares Held
132MCall Options Held
1.3MPut Options Held
395K-
Vanguard Group Inc Valley Forge, PA13.9MShares$144 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN9.93MShares$103 Million9.2% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD8.22MShares$85 Million2.48% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$61.8 Million0.02% of portfolio
-
State Street Corp Boston, MA5.02MShares$51.9 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.3B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...